LexDanaLexDanabeta
Inventor

Marcel Blommers

Inventor
Basel, CH

Overview

4→
Patents
2018–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes15%
C07CAcyclic or carbocyclic compounds15%
C07DHeterocyclic compounds15%
PatentTitleYear
11,008,5703' end caps for RNAi agents for use in RNA interference202110,519,446Organic compounds to treat hepatitis B virus201910,227,5883'end caps for RNAi agents for use in RNA interference20199,988,627Formats for organic compounds for use in RNA interference2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2021Patents assigned to NOVARTIS AG (4)· patent assignee history
2018–2019Patents assigned to BARYZA JEREMY LEE (2)· patent assignee history
2018–2019Patents assigned to BLOMMERS MARCEL (2)· patent assignee history
2018–2019Patents assigned to FERNANDEZ CESAR (2)· patent assignee history
2018–2019Patents assigned to GENO ERIN (2)· patent assignee history
2018–2021Based in Basel, CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG42018–2021
BARYZA JEREMY LEE22018–2019
BLOMMERS MARCELself22018–2019
FERNANDEZ CESAR22018–2019
GENO ERIN22018–2019
Locations
LocationPatentsSpan
Basel, CH42018–2021